This report describes neuronopathy, distal hereditary motor, autosomal dominant 14 (HMND14), which is a subtype of distal hereditary motor neuronopathy. The human gene implicated in this disease is DCTN1, which encodes dynactin 1 (p150, Glued (Drosophila) homolog), the largest polypeptide of the dynactin complex. There is one high-scoring fly ortholog, DCTN1-p150, for which RNAi targeting constructs, alleles caused by insertional mutagenesis, and classical amorphic alleles have been generated. DCTN1 is also associated with the diseases Perry syndrome (MIM:168605, FBhh0000114) and with an increased susceptibility to amyotrophic lateral sclerosis (MIM:105400, FBhh0000002). There is a second, moderate-scoring, ortholog in flies, Dred.
Multiple UAS constructs of the human Hsap\DCTN1 gene have been introduced into flies, including wild-type and a gene carrying a mutational lesion implicated in HMN7B. See the 'Disease-Implicated Variants' table below. Strong pan-neuronal overexpression of the wild-type human gene is toxic; low-level expression allows heterologous rescue (functional complementation) of the larval lethal phenotype of DCTN1-p150 amorphic mutations, however, the rescued adults are sterile. Phenotypes of variants analogous to those associated with Perry syndrome (FBhh0000114) have been compared to those associated with HMND14.
Homozygous amorphic mutations of Dmel\DCTN1-p150 are lethal in the embryonic or early larval stages. Heterozygous animals exhibit neuroanatomy defects, neurophysiology defects, and small roughened eyes.
[updated Feb. 2024 by FlyBase; FBrf0222196]
Distal hereditary motor neuronopathy (dHMN or HMN) is a heterogeneous group of neuromuscular disorders caused by anterior horn cell degeneration and characterized by progressive distal motor weakness and muscular atrophy of the peripheral nervous system without sensory impairment. Distal HMN is also referred to as spinal Charcot-Marie-Tooth disease (spinal CMT). Distal HMN is often referred to as a 'neuronopathy' instead of a 'neuropathy' based on the hypothesis that the primary pathologic process resides in the neuron cell body and not in the axons (Irobi et al., 2006, pubmed:16775372). [From MIM:607641, 2016.01.11]
[NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 14; HMND14](https://omim.org/entry/607641)
[DYNACTIN 1; DCTN1](https://omim.org/entry/601143)
Autosomal dominant distal hereditary motor neuronopathy-14 (HMND14) is a slowly progressive form of motor neuron disease without sensory symptoms. Onset of the disorder was in early adulthood with breathing difficulty due to vocal fold paralysis, progressive facial weakness, and weakness and muscle atrophy in the hands. Weakness and muscle atrophy in the distal lower extremities developed later (Puls, et al., 2003, pubmed:12627231). There is some phenotypic overlap between this disorder and amyotrophic lateral sclerosis (ALS; MIM:105400, FBhh0000002). [from MIM:607641; 2024.02.20]
Autosomal dominant distal hereditary motor neuronopathy-14 (HMND14) is caused by heterozygous mutation in the DCTN1 gene.
[from MIM:607641; 2024.02.20]
The DCTN1 gene encodes p150(Glued), the largest polypeptide of the dynactin complex, which binds directly to microtubules and to cytoplasmic dynein (DYNC1H1; MIM:600112), a microtubule-based biologic motor protein (Holzbaur and Tokito, 1996, pubmed:8838327). [From MIM:601143, 2016.01.08]
One to many: 1 human to 2 Drosophila.
High-scoring ortholog of human DCTN1 (2 Drosophila to 1 human); Dmel\DCTN1-p150 shares 34% identity and 55% similarity with the human gene.